Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
125 questions in 24 reviews · Injuries
current versionsNo studies 125 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Crash‐related injury rates · drivers or passengers travelling in passenger or commercial vehicles Education, incentive, and engineering‐based interventions to promote the use of seat belts (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Crash‐related mortality rates · drivers or passengers travelling in passenger or commercial vehicles Education, incentive, and engineering‐based interventions to promote the use of seat belts (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Crash‐related injury rates · drivers or passengers travelling in passenger or commercial vehicles Education, incentive, and engineering‐based interventions to promote the use of seat belts (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Crash‐related mortality rates · drivers or passengers travelling in passenger or commercial vehicles Education, incentive, and engineering‐based interventions to promote the use of seat belts (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Crash‐related injury rates · drivers or passengers travelling in passenger or commercial vehicles Education, incentive, and engineering‐based interventions to promote the use of seat belts (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Crash‐related mortality rates · drivers or passengers travelling in passenger or commercial vehicles Education, incentive, and engineering‐based interventions to promote the use of seat belts (2024) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage Transfusions (during hospital stay) ‐ not reported · cancer surgery Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage DVT (up to 90 days) ‐ not reported · cardiovascular (no bypass) surgeries Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage Volume (PPT) (during hospital stay) ‐ not reported · cancer surgery Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage Mortality (up to 90 days) ‐ not reported · obstetric surgeries Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage DVT (up to 90 days) ‐ not reported · obstetric surgeries Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage Infection (up to 90 days) ‐ not reported · obstetric surgeries Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage MI (up to 90 days) ‐ not reported · obstetric surgeries Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage CVA (stroke) (up to 90 days) ‐ not reported · obstetric surgeries Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage MI (up to 90 days) ‐ not reported · orthopaedic (hip) Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage Mortality (up to 90 days) ‐ not reported · orthopaedic (knee) Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage Mortality (up to 90 days) ‐ not reported · orthopaedic (spinal) Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage DVT (up to 90 days) ‐ not reported · orthopaedic (spinal) Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage MI (up to 90 days) ‐ not reported · orthopaedic (spinal) Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage CVA (stroke) (up to 90 days) ‐ not reported · orthopaedic (spinal) Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage MI (up to 90 days) ‐ not reported · cancer surgery Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage CVA (stroke) (up to 90 days) ‐ not reported · orthopaedic (mixed) Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Cell salvage vs no cell salvage CVA (stroke) (up to 90 days) ‐ not reported · cancer surgery Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery (2023) · Cochrane | no estimate extracted | NR | No studies |
Topical tranexamic acid vs placebo Re‐operation due to bleeding (7 days post‐surgery) ‐ not reported · people undergoing definitive fixation of hip, pelvic and long bone fractures Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Topical tranexamic acid vs placebo Risk of suspected serious drug reactions (30 days) ‐ not reported · people undergoing definitive fixation of hip, pelvic and long bone fractures Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intravenous tranexamic acid vs placebo Re‐operation due to bleeding (7 days post‐surgery) ‐ not reported · people undergoing definitive fixation of hip, pelvic and long bone fractures Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Glucocorticoid with cyclophosphamide plus usual care vs usual care (with or without placebo) Mortality at 30 days following the ingestion of paraquat · people with moderate to severe oral paraquat poisoning Glucocorticoid with cyclophosphamide for oral paraquat poisoning (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Poor outcome at the end of · adults with traumatic brain injury Interventions to reduce body temperature to 35 ⁰C to 37 ⁰C in adults and children with traumatic brain injury (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Serious intracranial haemorrhage · adults with traumatic brain injury Interventions to reduce body temperature to 35 ⁰C to 37 ⁰C in adults and children with traumatic brain injury (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Extracranial haemorrhage · adults with traumatic brain injury Interventions to reduce body temperature to 35 ⁰C to 37 ⁰C in adults and children with traumatic brain injury (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Abnormal intracranial pressure · adults with traumatic brain injury Interventions to reduce body temperature to 35 ⁰C to 37 ⁰C in adults and children with traumatic brain injury (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pneumonia or other serious infection · adults with traumatic brain injury Interventions to reduce body temperature to 35 ⁰C to 37 ⁰C in adults and children with traumatic brain injury (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Driving frequency Measured at end of study · teenagers, aged 17–19 years Mobility management to prevent, reduce, or delay driving a car in teenagers (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Driving distance Measured at the end of study · teenagers, aged 17–19 years Mobility management to prevent, reduce, or delay driving a car in teenagers (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Car crashes Measured at the end of study · teenagers, aged 17–19 years Mobility management to prevent, reduce, or delay driving a car in teenagers (2020) · Cochrane | no estimate extracted | NR | No studies |
Hypertonic saline vs other intracranial pressure‐lowering agents Pulmonary oedema during treatment · people with acute traumatic brain injury Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain… (2020) · Cochrane | no estimate extracted | NR | No studies |
Hypertonic saline vs other intracranial pressure‐lowering agents Acute renal failure during treatment · people with acute traumatic brain injury Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Fatal injuries — not measured · Workers in positions with safety‐sensitive functions, other than commercial drivers Random drug and alcohol testing for preventing injury in workers (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Non‐fatal injuries — not measured · Workers in positions with safety‐sensitive functions, other than commercial drivers Random drug and alcohol testing for preventing injury in workers (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Non‐injury accidents — not measured · Workers in positions with safety‐sensitive functions, other than commercial drivers Random drug and alcohol testing for preventing injury in workers (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Absenteeism — not measured · Workers in positions with safety‐sensitive functions, other than commercial drivers Random drug and alcohol testing for preventing injury in workers (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events associated with RAT — not measured · Workers in positions with safety‐sensitive functions, other than commercial drivers Random drug and alcohol testing for preventing injury in workers (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Acute pain · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Chronic pain · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Occupational effects · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Acute pain · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Chronic pain · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Occupational effects · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Acute pain · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Chronic pain · people with severe frostbite injuries Interventions for frostbite injuries (2020) · Cochrane | no estimate extracted | NR | No studies |